Data protection and privacy at EMA

The European Medicines Agency (EMA) collects and handles personal data in various situations. The documents on this page describe why and how EMA does this and what users can do to object.

The documents on this web page are data protection notices. They outline the legal grounds for EMA's data processing operations.

EMA collects and handles personal data in various situations and processes these data in line with EU law.

For details on how this website handles personal data, see Website data protection notice.

EMA only collects personal data to the extent necessary to perform its tasks.

The documents explain the purpose of collecting personal data and if EMA shares the data it collects with third parties. They also highlight what you can do to object to these processes.

To find out more about EMA, see:

• About us

Also on this topic

• Central register of data processing records

Communication

European Medicines Agency’s data protection notice for Product Management System (PMS) activities

Reference Number: EMA/109929/2025

European Medicines Agency’s data protection notice for Extended EudraVigilance Medicinal Production Dictionary (XEVMPD) processing activities

Reference Number: EMA/109932/2025

European Medicines Agency’s data protection notice for conducting surveys via EUSurvey

Reference Number: EMA/30411/2025

European Medicines Agency’s data protection notice for meeting registration forms via EUSurvey

Reference Number: EMA/27016/2025

European Medicines Agency's data protection notice for the handling of data subjects’ requests

Reference Number: EMA/116897/2024

European Medicines Agency’s data protection notice for the Cisco Webex meetings and Webex events participants

Reference Number: EMA/304030/2023

European Medicines Agency’s data protection notice For the electronic EMA newsletters published via Newsroom

Reference Number: EMA/301502/2023

European Medicines Agency’s data protection notice for the EMA Help Desk

Reference Number: EMA/123948/2023 Rev.1

European Medicines Agency's data protection notice concerning the Annual ESVAC Network meeting on 3 May 2022

Reference Number: EMA/193804/2022

European Medicines Agency's data protection notice concerning the VMP-Reg stakeholders meetings

Reference Number: EMA/173739/2022

European Medicines Agency's privacy statement for media professionals

Reference Number: EMA/416293/2020

European Medicines Agency’s privacy statement for managed print services

Reference Number: EMA/175429/2020

European Medicines Agency’s privacy statement for electronic newsletters

Reference Number: EMA/288337/2020

European Medicines Agency’s privacy statement for the Information Centre

Reference Number: EMA/634004/2019

European Medicines Agency's privacy statement for the organisation of meetings and events

Reference Number: EMA/75470/2019

European Medicines Agency’s data protection notice for recording of telephone calls to the EMA official telephone number received at the EMA switchboard

Reference Number: EMA/542660/2020

European Medicines Agency's data protection notice concerning the Multistakeholder Workshop on EMA extended mandate on 1 April 2022

Reference Number: EMA/112793/2022

Corporate

European Medicines Agency’s data protection notice for the management of traineeships at EMA

Reference Number: EMA/355081/2024

European Medicines Agency’s data protection notice for women leadership development and mentoring activities

Reference Number: EMA/59131/2026

European Medicines Agency’s data protection notice for personal data relating to temporary agency workers (‘interims’)

Reference Number: EMA/48615/2026

European Medicines Agency’s data protection notice for mail management

Reference Number: EMA/EXT/269377/2025

European Medicines Agency’s data protection notice for the processing of personal data contained in the Agency’s historical records selected for permanent preservation and opening to the public

Reference Number: EMA/559852/2024

European Medicines Agency’s data protection notice for publication of contact details of industry representatives in Agile teams

Reference Number: EMA/282298/2023

European Medicines Agency’s data protection notice for the procedure for handling and reporting internally potential fraud and irregularities

Reference Number: EMA/905403/2022

European Medicines Agency’s Privacy Statement for the provision of hotel and travel services through the Agency’s online booking tool

Reference Number: EMA/179740/2022

European Medicines Agency’s Data Protection Notice for the operation of video-surveillance (CCTV) system

Reference Number: EMA/150897/2021

European Medicines Agency’s data protection notice regarding the Experts Management Tool and the handling of competing interests

Reference Number: EMA/283094/2023 Rev. 2

European Medicines Agency privacy statement for the publication of post-employment decisions regarding senior staff (Article 16 of Staff Regulations)

Reference Number: EMA/641439/2020

European Medicines Agency’s data protection notice for the pre-employment medical examination

Reference Number: EMA/525037/2023

European Medicines Agency's data protection notice for selection and recruitment

Reference Number: EMA/208342/2019

European Medicines Agency's data protection notice for the processing of personal data in the context of public procurement procedures

Reference Number: EMA/13742/2019 Rev.2

European Medicines Agency’s privacy statement on the processing of personal data in the context of administrative inquiries and disciplinary proceedings

Reference Number: EMA/868447/2018

European Medicines Agency’s privacy statement for the EMA individual experts’ stakeholder database

Reference Number: EMA/351266/2019 Summary:

This privacy statement provides details on how the European Medicines Agency (hereinafter “EMA” or “Agency”) will process your personal data that submitted for the purpose of registering in the EMA individual experts’ stakeholder database (hereinafter “Database”).

European Medicines Agency’s privacy statement concerning public hearings at the European Medicines Agency

Reference Number: EMA/349369/2019 Summary:

This privacy statement provides details on how the European Medicines Agency (hereinafter “EMA” or “Agency”) will process your personal data that you have submitted for the purpose of attending a public hearing at EMA’s safety committee, the Pharmacovigilance Risk Assessment Committee (PRAC).

Data protection notice for legal entity and bank account validation regarding payments

Reference Number: EMA/445121/2019

European Medicines Agency’s privacy statement for the visitor management application

Reference Number: EMA/233274/2021

European Medicines Agency’s data protection notice for parking access and record of lost and found items (Filemaker internal security database)

Reference Number: EMA/232805/2021

Human medicine

European Medicines Agency's data protection notice for Modelling and Simulation Pilot - Use of clinical study data for scientific advice

Reference Number: EMA/76223/2026

European Medicines Agency’s data protection notice for the exchange of information during the Critical Medicines Vulnerability Assessment exercise

Reference Number: EMA/78505/2026

European Medicines Agency’s data protection notice regarding personal data processing in the Clinical Trials Information System (CTIS)

Reference Number: EMA/587422/2024

European Medicines Agency’s data protection notice for the Antimicrobials Sales and Use platform

Reference Number: EMA/104751/2023

European Medicines Agency’s data protection notice for grant procedures

Reference Number: EMA/568334/2023

European Medicines Agency’s data protection notice for the user test of the Critical Medical Device Shortages (CMDS) system

Reference Number: EMA/335709/2023

European Medicines Agency’s data protection notice for the clinical study data proof-of-concept pilot

Reference Number: EMA/716436/2022

European Medicines Agency’s data protection on notice for certificates of medicinal products

Reference Number: EMA/134763/2022

European Medicines Agency’s data protection notice concerning the processing of patient and product traceability data for Zynteglo following the withdrawal of the marketing authorisation

Reference Number: EMA/198331/2022

European Medicines Agency’s data protection notice for the processing of the contact points of scientific committees (CXMP) members/alternates’ for internal use by the same committees

Reference Number: EMA/67519/2022

European Medicines Agency’s privacy statement for the clinical data publication website

Reference Number: EMA/88784/2021

European Medicines Agency’s privacy statement for the Industry Single Point of Contact (i-SPOC) system

Reference Number: EMA/222043/2020

Privacy statement concerning European Medicines Agency’s public stakeholder meetings on COVID-19 vaccines

Reference Number: EMA/669919/2020

European Medicines Agency’s privacy statement for the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Resource Database

European Medicines Agency’s privacy statement public and targeted consultations

Reference Number: EMA/472380/2019

European Medicines Agency’s data protection notice for the EudraVigilance Signal and Safety Analytics (EV SSA) platform

Reference Number: EMA/228281/2024

Information technology (IT)

European Medicines Agency’s data protection notice for sharing contact details of network representatives in Agile teams via the restricted Network Portfolio website

Reference Number: EMA/76073/2026

European Medicines Agency’s data protection notice for PMS user acceptance stakeholder involvement

Reference Number: EMA/57555/2025

European Medicines Agency’s data protection notice for Microsoft (MS) Copilot 365 - EMA pilot phase

Reference Number: EMA/216030/2025

European Medicines Agency’s data protection notice for the use of EMA Authentication Services and Microsoft Entra ID

Reference Number: EMA/124625/2025

European Medicines Agency’s Data Protection Notice for the Organisation Management System (OMS) activities

Reference Number: EMA/565742/2023

European Medicines Agency’s data protection notice for the EU NTC learning management system

Reference Number: EMA/184133/2025

European Medicines Agency’s data protection notice for the European shortages monitoring platform (ESMP)

Reference Number: EMA/88329/2025

European Medicines Agency’s data protection notice for the audiovisual tool for checking presence in meeting rooms

Reference Number: EMA/177150/2024

European Medicines Agency’s data protection notice for Scientific Explorer

Reference Number: EMA/119597/2024

European Medicines Agency’s data protection notice for the exploration of the DEEP platform

Reference Number: EMA/5888197/2023

European Medicines Agency's data protection notice for the Security Operation Centre (SOC)

Reference Number: EMA/684090/2022

European Medicines Agency’s Data Protection Notice for the use of Microsoft Applications: OneDrive, Outlook 365, Teams and SharePoint

Reference Number: EMA/188185/2023 Rev.2

European Medicines Agency's data protection notice for Microsoft Edge

Reference Number: EMA/123801/2023

European Medicines Agency's data protection notice for use of Microsoft Intune for personal and corporate-owned devices

Reference Number: EMA/124004/2023

European Medicines Agency’s data protection notice for the European Union (EU) Metadata Catalogue

Reference Number: EMA/114219/2023

European Medicines Agency’s data protection notice for the operation of the Security Access Control System

Reference Number: EMA/225532/2023

European Medicine Agency's data protection notice for the Interactive Regulatory Information System (IRIS)

Reference Number: EMA/338056/2023

European Medicines Agency’s data protection notice use of personal data as part of the emergency mass notification system

Reference Number: EMA/519784/2019

European Medicines Agency’s privacy statement for the use of Microsoft Teams and SharePoint Online pilot users (obsolete)

Reference Number: EMA/330262/2020 Summary:

European Medicines Agency’s Privacy Statement for the use of Microsoft Teams and SharePoint Online pilot users

European Medicines Agency’s privacy statement concerning requests for information or access to documents via 'Send a question' form or phone call

Reference Number: EMA/415481/2019 Rev. 2 Summary:

European Medicines Agency’s Privacy Statement concerning requests for information or access to documents

European Medicines Agency’s data protection notice for the EMA Account Management system

Reference Number: EMA/112375/2026

Regulatory

European Medicines Agency's data protection notice for the implementation of the Instrument for Pre-accession Assistance (IPA) programme

Reference Number: EMA/368013/2025

European Medicines Agency’s data protection notice for the TRIP digital workstation for horizon scanning and regulatory science

Reference Number: EMA/321117/2015

European Medicines Agency’s data protection notice for the Referentials Management System (RMS) activities

Reference Number: EMA/315609/2024

European Medicines Agency’s data protection notice for regulatory science and innovation task force (TRS) activities

Reference Number: EMA/79065/2024

European Medicines Agency’s Data Protection Notice For the Risk Management Plans Publication Process

Reference Number: EMA/219344/2024

European Medicines Agency's privacy statement for SME status applications submitted by natural persons

Reference Number: EMA/550671/2020

European Medicines Agency’s privacy statement for the EU Innovation Network

Reference Number: EMA/317033/2020

European Medicines Agency’s privacy statement for the Regulatory Science Strategy interviews

Reference Number: EMA/317034/2020

European Medicines Agency’s privacy statement for Small and Medium Enterprises (SME) Office activities

Reference Number: EMA/420340/2019 Rev. 1

European Medicines Agency’s data protection notice for validation of proof of establishment when natural persons apply for orphan designation or a transfer of an orphan designation

Reference Number: EMA/285766/2020

European Medicines Agency’s data protection notice for EudraVigilance Human (EV)

Reference Number: EMA/381993/2024

Studies

European Medicines Agency’s data protection notice for the HMA-EMA Catalogue of real-world data studies

Reference Number: EMA/60093/2024

European Medicines Agency's data protection notice for the HMA-EMA Catalogue of real-world data sources (and networks and institutions)

Reference Number: EMA/110797/2023

European Medicines Agency’s privacy statement for the European Union electronic Register of Post-Authorisation Studies (EU PAS Register)

European Medicines Agency's data protection notice on the study of the “Natural history of coagulopathy in COVID-19 patients and persons vaccinated against SARS-CoV- during the Omicron period”

Reference Number: EMA/221505/2024

European Medicines Agency's data protection notice on the use of SNDS data for the performance of DARWIN EU® studies on incidence and prevalence of pathologies and use of drugs in the French population

Reference Number: EMA/89626/2025

Veterinary medicine

European Medicines Agency data protection notice concerning the 3rd Veterinary Stakeholder Forum on 23 November 2023

Reference Number: EMA/295350/2023

European Medicines Agency data protection notice concerning the EMA Veterinary Awareness Day event on 12-13 September 2023

Reference Number: EMA/295351/2023

European Medicines Agency's data protection notice concerning the Veterinary Info Day meeting on 16-17 February 2023

Reference Number: EMA/931102/2022

European Medicines Agency data protection notice concerning the Veterinary Info Day meeting on 12-13 May 2022

Reference Number: EMA/194250/2022

European Medicines Agency’s data protection notice for the Union Product Database

Reference Number: EMA/686248/2020 Rev.2

European Medicines Agency’s privacy statement for the usability testing of the restricted area of the Union Product Database

Reference Number: EMA/309427/2021

European Medicines Agency’s privacy statement for user research for the design of the Union Product Database

Reference Number: EMA/11841/2021 Rev. 1